Rephonic
Artwork for Biotech Hangout
FDA
Biotech
Mergers and Acquisitions
China
Biotech Industry
Biotech Sector
Gene Therapy
Drug Pricing
Obesity
Clinical Trials
M&A
XBI
IPO
Investor Sentiment
Jpmorgan Healthcare Conference
Sarepta
Vaccines
Obesity Treatment
M&A Activity
Car-T Therapy

A weekly discussion of all things biotech – breaking news, data, deals, and FDA actions – with a community of biotech industry leaders and experts. Join the live streams hosted by @BiotechCH, @daphnezohar, @bradloncar and @biotech1 on Twitter Spaces every Friday at 12pm ET.

PublishesWeeklyEpisodes167Founded5 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for Biotech Hangout

Latest Episodes

On this week's episode, Graig Suvannavejh, Sam Fazeli, Eric Schmidt, and Brian Skorney open with a look at the public markets, noting the XBI is up 27% year-to-date but down about 9% since its August high. The co-hosts then touched on Oura's pulled I... more

YouTube

On this week's episode, Sam Fazeli, Yaron Werber, Brian Skorney, and Matt Gline open with the IPO market, noting record average raise sizes even as XBI softens. The group turns to policy, unpacking newly FOIA-disclosed details of Pfizer's MFN agreeme... more

YouTube

On this week's episode, Josh Schimmer, Eric Schmidt, Paul Matteis, and guest Adam Feuerstein open with the OpenAI/Hugging Face AI agent controversy, debating whether calls for AI regulation reflect genuine safety concern or capital rotating out of bi... more

YouTube

On this week's episode, Tess Cameron, Brian Skorney, Paul Matteis, and Yaron Werber open with a look at markets, noting the XBI slipped just over 3% amid concerns about energy prices, inflation, and long-term U.S. fiscal health weighing on the rate-s... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Jake Becraft
CEO of Strand Therapeutics, private biotech company
Strand Therapeutics
Episode: Episode 192 - August 7, 2026
Matt Herper
Special guest from STAT
Episode: Episode 188 - July 10, 2026
Jason Kelly
Co-founder and CEO of Ginkgo Bioworks
Episode: Episode 184 - May 29, 2026
Allison DeAngelis
Special guest
Episode: Episode 182 - May 8, 2026
Oliver Barnes
Journalist, Financial Times
Financial Times
Episode: Episode 179 - April 10, 2026
John Stanford
Host of the Making Medicines podcast
Making Medicines
Episode: Episode 166 - December 12, 2025
Drew Armstrong
Biotech reporter
Endpoints News
Episode: Episode 163 - November 14, 2025
Adam Feuerstein
Noted biotech journalist and commentator
STAT News
Episode: Episode 148 - July 18, 2025
Matt Gline
Special guest and industry expert
Episode: Episode 135 - March 21, 2025

Hosts

Tess Cameron
Host and frequent panelist on industry discussions, with focus on biotech news and market dynamics.
Daphne Zohar
Co-host with deep industry connections, contributing to live biotech policy and market discussions.
Sam Fazeli
Host with a strong focus on market dynamics, biotech investing, and regulatory context.
Yaron Werber
Co-host offering industry insights and strategic perspectives on deals and regulation.
Paul Matteis
Co-host contributing to market analysis and regulatory discussions.

Reviews

4.7 out of 5 stars from 97 ratings
  • Informative Podcasts

    I started listening to this podcast to check out on the current state of drug market, investor’s interests, FDA state of affairs and much more, in one place. I learn quite a bit from here.

    Apple Podcasts
    5
    DrugWatcher
    United States3 months ago
  • Really Great Podcast

    I am new to listening to podcasts but this has quickly become my favorite one. I know the audio is bad sometimes but other than that the insights are really awesome and great to learn from. Please continue making more, I love listening!

    Apple Podcasts
    5
    Mpat5!
    United States5 months ago
  • Fantastic conversations, but the audio quality is extremely poor

    It looks like listeners have been pointing this out for more than three years — great discussions from experienced insiders, but terrible audio. I am not sure why the production team has not made even a small effort to improve it. It is a shame, because about ~15 minutes out of each episode are not even understandable.

    Apple Podcasts
    3
    Oncoproteins
    United States10 months ago
  • Great content, audio is unbearable

    Great content and discussions but the audio/lack of editing is so terrible I won’t be listening again. Please fix your audio so we can enjoy the podcast!!

    Apple Podcasts
    3
    Impostersyyndrome
    United States2 years ago
  • Excellent content, terrible audio quality

    Please improve audio

    Apple Podcasts
    3
    tgjoufdee
    United States3 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Great insights for investors and operators, even when audio quality is a hurdle.
Asset for understanding how policy shifts affect biotech financing and approvals.
Strong guest mix and pragmatic views on biotech strategy and market timing.
Very informative discussions, with data-driven takes on FDA and deal-making.
High-caliber inside perspectives; content is worth sticking with despite production quirks.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Episode 184 - May 29, 2026
Q: How do you view the Coins Act and national security concerns impacting drug development and licensing overseas?
The discussion centers on balancing national security and competitive innovation, arguing that overly restrictive licensing could hinder US leadership and that the US should maintain a free market capacity while ensuring domestic capabilities.
Episode 179 - April 10, 2026
Q: Sam, did I get that right? Is it JATO?
Sam confirms the bid details and emphasizes the scale and strategic significance of the financing and funds, clarifying the European fund's size and its role in biopharma.
Episode 166 - December 12, 2025
Q: How are funding decisions made in the DoD compared to NIH?
The DoD prioritizes funding relative to global advancements, often influenced by what other countries like China are achieving.
Episode 153 - September 5, 2025
Q: John, how do you feel about the introduction of gene therapy versus traditional treatment methods?
Gene therapy might take longer to reach broad populations, focusing on preventive rather than therapeutic approaches seems more practical now.
Episode 153 - September 5, 2025
Q: Graig, what are your thoughts on the investment strategies relating to obesity drugs?
It seems investors react swiftly to new data, making the market quite volatile and competitive as efficacy measures shift.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Biotech Hangout

What is Biotech Hangout about and what kind of topics does it cover?

A weekly, live panel-style show that threads together biotech investing, policy shifts, regulatory news, and clinical readouts. Across episodes, discussions routinely cover FDA leadership and decision-making, major drug approvals and acquisitions, market dynamics in biotech stocks, and the evolving role of AI and data in drug discovery. Guests and hosts dissect trial designs, pricing debates, and global dynamics (notably US-China activity), offering practical takeaways for investors, operators, and patients. A standout pattern is the blend of high-quality technical scrutiny with real-time market context, making it a go-to for staying ahead of headlines and understanding the implications for development pipelines and financing strategies. Th... more

Where can I find podcast stats for Biotech Hangout?

Rephonic provides a wide range of podcast stats for Biotech Hangout. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Biotech Hangout and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Biotech Hangout get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Biotech Hangout, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Biotech Hangout?

Rephonic provides comprehensive predictive audience data for Biotech Hangout, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Biotech Hangout have?

To see how many followers or subscribers Biotech Hangout has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Biotech Hangout?

These podcasts share a similar audience with Biotech Hangout:

1. BioCentury This Week
2. The Readout Loud
3. The Long Run with Luke Timmerman
4. Business Of Biotech
5. The BioCentury Show

How many episodes of Biotech Hangout are there?

Biotech Hangout launched 5 years ago and published 167 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Biotech Hangout?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Biotech Hangout?

Rephonic pulls ratings and reviews for Biotech Hangout from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Biotech Hangout?

Rephonic provides full transcripts for episodes of Biotech Hangout. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Biotech Hangout?

Recent guests on Biotech Hangout include:

1. Jake Becraft
2. Matt Herper
3. Jason Kelly
4. Allison DeAngelis
5. Oliver Barnes
6. John Stanford
7. Drew Armstrong
8. Adam Feuerstein

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days